Similarly, He et al. [62] found that persistence of high serum levels of MALAT1, AFAP1-AS1, and AL359062 lncRNAs following treatment was associated with recurrence, residual NPC in lymph nodes, or metastasis. This evidence concerns the gene MALAT1 and nasopharyngeal carcinoma.